| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/07/2013 | WO2013018706A1 Composition for regulating urat1 activity |
| 02/07/2013 | WO2013018695A1 Heterocyclic compound |
| 02/07/2013 | WO2013017475A1 New use of l-histidine and derivatives thereof |
| 02/07/2013 | US20130035368 Oligonucleotide compounds comprising non-nucleotide overhangs |
| 02/07/2013 | US20130035354 Aryl pyridine as aldosterone synthase inhibitors |
| 02/07/2013 | US20130035339 Apoptosis signal-regulating kinase inhibitors |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
| 02/07/2013 | US20130035298 Pharmaceutical composition, methods for treating and uses thereof |
| 02/07/2013 | US20130035290 Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury |
| 02/07/2013 | US20130034587 Methods for treatment of incontinence associated with sexual activity |
| 02/07/2013 | CA2844030A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | CA2842906A1 Left ventricular diastolic function improving agent |
| 02/07/2013 | CA2842802A1 Non-digestible capsules for the delivery of fluid absorbing materials |
| 02/06/2013 | EP2554168A1 Controlled release pharmaceutical composition |
| 02/06/2013 | EP2554167A1 New use of l-histidine and derivatives thereof |
| 02/06/2013 | EP2552910A1 New polymorph |
| 02/06/2013 | EP2552888A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion" |
| 02/06/2013 | EP2552443A1 Improved treatment of renal cell carcinoma |
| 02/06/2013 | CN102918059A Anti-CD27 antibody |
| 02/06/2013 | CN102918038A 新的多晶型物 The new polymorph of |
| 02/06/2013 | CN102917703A Novel EP4 agonist |
| 02/06/2013 | CN102914658A Application of CRISP3 protein on diagnosis and treatment of prostate cancer |
| 02/06/2013 | CN102911843A Preparation method of eclipta alba hair-blacking wine |
| 02/06/2013 | CN102911179A Lcotinib hydrochloride crystal form, medicinal composition and application |
| 02/06/2013 | CN102908579A Traditional Chinese medicine preparation for treating gynecological diseases, liver diseases and prostatitis and preparation method of traditional Chinese medicine preparation |
| 02/06/2013 | CN102908568A Method of preparing medication--mantis egg-case and sticky rice powder for treatment of enuresis |
| 02/06/2013 | CN102908560A Traditional Chinese medicine for treating kidney stones and preparation method of same |
| 02/06/2013 | CN102908557A Medicine for treating nephritis and damp/heat toxin and preparation method of same |
| 02/06/2013 | CN102908551A Medicinal tea capable of dissolving stones in body and preparation method thereof |
| 02/06/2013 | CN102908543A Traditional Chinese medicine composition for treating prostatitis and preparation method thereof |
| 02/06/2013 | CN102908540A Chinese medicinal medicament for treating cystitis |
| 02/06/2013 | CN102908522A Chinese herbal medicine for curing benign prostatic hyperplasia by hedyotis diffusa wilid |
| 02/06/2013 | CN102908467A Traditional Chinese medicine for treating hematuria |
| 02/06/2013 | CN102908453A Double-tonifying pills |
| 02/06/2013 | CN102908438A Kidney invigorating, essence strengthening, qi reinforcing, blood nourishing and body immunity improving capsules |
| 02/06/2013 | CN102908423A Chinese medicinal composition for treating stones |
| 02/06/2013 | CN102908386A Traditional Chinese medicine for treating kidney stone |
| 02/06/2013 | CN102146074B Preparation method of pyrrole derivative and application thereof |
| 02/05/2013 | CA2557766C Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 02/05/2013 | CA2526872C Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 02/05/2013 | CA2501719C Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 01/31/2013 | WO2013014205A1 Substituted 3 - (thiazole - 4 - carbonyl) - or 3 - (thiazole - 2 - carbonyl) aminopropionic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | WO2013014204A2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | US20130030057 METHODS AND COMPOSITIONS COMPRISING AT LEAST ONE ALPHA3 BETA4 nAChR ANTAGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |
| 01/31/2013 | US20130030033 4-trimethylammonio-butyrates as cpt2 inhibitors |
| 01/31/2013 | US20130030020 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds |
| 01/31/2013 | US20130030006 Agent for preventing or treating diseases accompanied by urinary pain |
| 01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029985 Novel Compounds |
| 01/31/2013 | US20130029977 Fused substituted aminopyrrolidine derivative |
| 01/31/2013 | US20130029968 Indazoles |
| 01/31/2013 | US20130029966 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 01/31/2013 | US20130029963 1,2,4-triazine-4-amine derivatives |
| 01/31/2013 | US20130029961 Substituted Heterocyclic Aza Compounds |
| 01/31/2013 | US20130029948 Heterocyclic autotaxin inhibitors and uses thereof |
| 01/31/2013 | US20130029900 Novel maytansinoid derivatives with peptide linker and conjugates thereof |
| 01/31/2013 | US20130028993 Composition and Manufacturing Processes of a Toxicity Free Botanical Drug for Curative Treatment of Chronic Diseases |
| 01/31/2013 | US20130028982 Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders |
| 01/31/2013 | US20130028877 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS |
| 01/31/2013 | US20130028870 Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease |
| 01/31/2013 | CA2841911A1 Substituted 3 - (thiazole - 4 - carbonyl) - or 3 - (thiazole - 2 - carbonyl) - aminopropionic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | CA2841905A1 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/30/2013 | EP2550965A2 Ceramide derivatives for treating polycystic kidney disease |
| 01/30/2013 | EP2550002A1 Rna interference in dermal and fibrotic indications |
| 01/30/2013 | EP2549872A1 Trpv4 antagonists |
| 01/30/2013 | CN202699643U Compound tamsulosin-finasteride capsule |
| 01/30/2013 | CN102906074A Fused imidazole derivative |
| 01/30/2013 | CN102905706A Pharmaceutical composition containing solifenacin |
| 01/30/2013 | CN102899261A Isolated bifidobacterium longum subsp. longum capable of producing high cell immunity reaction |
| 01/30/2013 | CN102898452A Heterocyclic compound as TRPV1 blocker, pharmaceutical composition, and pharmaceutical use thereof |
| 01/30/2013 | CN102898432A Tricyclic compound |
| 01/30/2013 | CN102898417A Benzo-hexahydric nitrogenous heterocycle derivative |
| 01/30/2013 | CN102898364A Heterocyclic inhibitors of MEK and methods of use thereof |
| 01/30/2013 | CN102898349A Solid containing compound, a composition containing the solid and use of the solid |
| 01/30/2013 | CN102895656A Adenosine triphosphate-coenzyme-insulin compound-containing pharmaceutical composition |
| 01/30/2013 | CN102895629A Preparation technology and production method for integrated new formulation of cassia twig and oyster decoction |
| 01/30/2013 | CN102895618A Preparation technology and production method for integrated new formulation of snakegourd root and cassia twig decoction |
| 01/30/2013 | CN102895617A Preparation technology and production method for integrated new formulation of bighead atractylodes rhizome and monkshood decoction |
| 01/30/2013 | CN102895612A Preparation technology of integrated novel preparation of yuebi pinellia decoction |
| 01/30/2013 | CN102895597A Drug for treating urinary calculus |
| 01/30/2013 | CN102895580A Pulse invigorating and kidney tonifying medicament |
| 01/30/2013 | CN102895563A Medicine for treating urinary retention after cesarean section |
| 01/30/2013 | CN102895554A Preparation method of medicament calculus removing powder for treatment of calculosis |
| 01/30/2013 | CN102895553A Preparation technology and production method for integrated new formulation of ephedra, apricot kernel, coix and licorice decoction |
| 01/30/2013 | CN102895551A Traditional Chinese medicine for treating chronic renal failure |
| 01/30/2013 | CN102895550A Traditional Chinese medicine for treating glomerulonephritis |
| 01/30/2013 | CN102895543A Traditional Chinese medicine detoxifying decoction for treating uremia |
| 01/30/2013 | CN102895540A Drug for treatment of hydronephrosis |
| 01/30/2013 | CN102895531A Decoction medicine for treatment of nephritis enduring type proteinuria |
| 01/30/2013 | CN102895487A Production process of prostatic disease treating particles |
| 01/30/2013 | CN102895457A Preparation technology and production method for integrated new formulation of golden chamber kidney qi pill |
| 01/30/2013 | CN102895444A Traditional Chinese medicine composition for treating lithangiuria |
| 01/30/2013 | CN102895435A Decoction of traditional Chinese medicine enema for treating uremia |
| 01/30/2013 | CN102895428A Chinese medicine treatment method for dog and cat urinary calculus |
| 01/30/2013 | CN102895427A Drug for treating urinary system infection |
| 01/30/2013 | CN102895424A Preparation method of drug, calculus-removing powder, for treating urolithiasis |
| 01/30/2013 | CN102895384A Chinese herbal medicine compound preparation for removing pathogenic heat from blood and securing essence and method for preparing Chinese herbal medicine compound preparation |
| 01/30/2013 | CN102895348A Pharmaceutical compositions for treating rheumatic joint disease, preparation method thereof and use thereof |